Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical Xpress
Researchers reported changes in brain functional connectivity after adding N-acetylcysteine to ongoing multiple sclerosis treatment, an early imaging signal that requires confirmation in larger studies with defined dosing and clinical outcomes.
Clinical Pharmacology November 3rd 2026
News Medical
Losartan increased brown-fat metabolic activity in cell and mouse experiments, while a large imaging analysis linked brown fat and ARB exposure with favorable metabolic patterns. Whether the drug can produce similar metabolic effects clinically remains unproven.
Cardiology October 26th 2026
A patient with advanced, treatment-resistant lung cancer experienced complete tumor disappearance after sodium selenite treatment and remained tumor-free for 10 years. The single case cannot establish efficacy, safety, or causality.
Internal Medicine September 2nd 2026
Healthline
Two phase 3 trials found upadacitinib increased scalp, eyebrow, and eyelash regrowth in adolescents and adults with severe alopecia areata. Longer-term safety, durability, and regulatory review remain important considerations.
Dermatology September 2nd 2026
Cancer Therapy Advisor
A community oncologist previewed four ASCO 2026 late-breaking abstracts spanning pancreatic, prostate, lung, and sarcoma, flagging molecular testing infrastructure and toxicity coordination as key implementation questions ahead of the data readout.
Hematology/Oncology May 26th 2026
MDSpire News
The reseachers acknowledge that the Delphi approach favors compounds already studied and may exclude agents identifiable only through high-throughput screening.
Neurology March 5th 2026